Collins P C, Miller W M, Papoutsakis E T
Northwestern University, Department of Chemical Engineering, Evanston, Illinois 60208-3120, USA.
Biotechnol Bioeng. 1998 Sep 5;59(5):534-43. doi: 10.1002/(sici)1097-0290(19980905)59:5<534::aid-bit2>3.0.co;2-b.
The ability to culture hematopoietic cells in readily characterizable and scalable stirred systems, combined with the capability to utilize serum-free medium, will aid the development of clinically attractive bioreactor systems for transplantation therapies. We thus examined the proliferation and differentiation characteristics of peripheral blood (PB) mononuclear cells (MNC), cord blood (CB) MNC, and PB CD34(+) cells in spinner flasks and (control) T-flask cultures in both serum-containing and serum-free media. Hematopoietic cultures initiated from all sources examined (PB MNC, CB MNC, and PB CD34(+) cells) grew well in spinner vessels with either serum-containing or serum-free medium. Culture proliferation in spinner flasks was dependent on both agitator design and RPM as well as on the establishment of critical inoculum densities (ID) in both serum-containing (2 x 10(5) MNC/mL) and serum-free (3 x 10(5) MNC/mL) media. Spinner flask culture of PB MNC in serum-containing medium provided superior expansion of total cells and colony-forming cells (CFC) at high ID (1.2 x 10(6) cells/mL) as compared to T-flask controls. Serum-free spinner culture was comparable, if not superior, to that observed in serum-containing medium. This is the first report of stirred culture of PB or CB MNC, as well as the first report of stirred CD34(+) cell culture. Additionally, this is the first account of serum-free stirred culture of hematopoietic cells from any source.
在易于表征和可扩展的搅拌系统中培养造血细胞的能力,再加上使用无血清培养基的能力,将有助于开发临床上有吸引力的用于移植治疗的生物反应器系统。因此,我们研究了外周血(PB)单个核细胞(MNC)、脐血(CB)MNC和PB CD34(+)细胞在含血清和无血清培养基中的转瓶和(对照)T瓶培养中的增殖和分化特性。从所有检测来源(PB MNC、CB MNC和PB CD34(+)细胞)起始的造血培养物在含血清或无血清培养基的转瓶中生长良好。转瓶中的培养增殖取决于搅拌器设计、转速以及在含血清(2×10(5) MNC/mL)和无血清(3×10(5) MNC/mL)培养基中建立临界接种密度(ID)。与T瓶对照相比,在含血清培养基中转瓶培养PB MNC在高ID(1.2×10(6)细胞/mL)时可使总细胞和集落形成细胞(CFC)得到更好的扩增。无血清转瓶培养即便不比含血清培养基中的培养优越,至少也是相当的。这是关于PB或CB MNC搅拌培养的首篇报道,也是搅拌培养CD34(+)细胞的首篇报道。此外,这是关于任何来源造血细胞无血清搅拌培养的首次报道。